Even with access to a clinical trial, cancer patients living in the poorest neighborhoods in America have a nearly 30% greater chance of dying from their disease compared to the wealthiest patients, SWOG Cancer Research Network study results show. Published in the Journal of Clinical Oncology, the findings illustrate the stubbornly harmful effects of […]
Social distancing and lockdowns may have reduced the spread of COVID-19, but researchers from Penn State College of Medicine also report those actions may have affected clinical researchers’ ability to finish trials. Between April and October 2020, study completion rates dropped worldwide between 13% and 23%, depending on the type of research sponsor and […]
New research from the University of Virginia (UVA) Cancer Center could rescue once-promising immunotherapies for treating solid cancer tumors, such as ovarian, colon, and triple-negative breast cancer, that ultimately failed in human clinical trials. The research led by UVA’s Jogender Tushir-Singh, PhD, explains why the antibody approaches effectively killed cancer tumors in lab tests but proved […]
A new survey conducted by researchers at Georgetown, Rutgers, Johns Hopkins, and 1Day Sooner finds that the overwhelming majority of nearly 2,000 potential COVID-19 human challenge trial volunteers who were surveyed are motivated by a desire to help others and have typical responses to risk, allaying a key concern that volunteers for such trials […]
